IdentificationGeneric Name(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINEDrugBank Accession NumberDB07860BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE (DB07860)× CloseWeightAverage: 231.721 Monoisotopic: 231.08147716 Chemical FormulaC14H14ClNSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUcAMP-dependent protein kinase catalytic subunit alphaNot AvailableHumansUcAMP-dependent protein kinase inhibitor alphaNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassDiphenylmethanesDirect ParentDiphenylmethanesAlternative ParentsChlorobenzenes / Aralkylamines / Aryl chlorides / Organopnictogen compounds / Organochlorides / Monoalkylamines / Hydrocarbon derivativesSubstituentsAmine / Aralkylamine / Aromatic homomonocyclic compound / Aryl chloride / Aryl halide / Chlorobenzene / Diphenylmethane / Halobenzene / Hydrocarbon derivative / Organic nitrogen compoundMolecular FrameworkAromatic homomonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyPNKKPFLBOWGVSF-CQSZACIVSA-NInChIInChI=1S/C14H14ClN/c15-13-8-6-12(7-9-13)14(10-16)11-4-2-1-3-5-11/h1-9,14H,10,16H2/t14-/m1/s1IUPAC Name(2R)-2-(4-chlorophenyl)-2-phenylethan-1-amineSMILES[H][C@@](CN)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound16122635PubChem Substance99444331ChemSpider17279548ZINCZINC000002576552PDBe LigandGVQPDB Entries2uw8Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0163 mg/mLALOGPSlogP3.74ALOGPSlogP3.49ChemaxonlogS-4.2ALOGPSpKa (Strongest Basic)9.7ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count1ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area26.02 Å2ChemaxonRotatable Bond Count3ChemaxonRefractivity68.66 m3·mol-1ChemaxonPolarizability25.29 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleYesChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9942Blood Brain Barrier+0.9766Caco-2 permeable+0.8036P-glycoprotein substrateNon-substrate0.7949P-glycoprotein inhibitor INon-inhibitor0.9301P-glycoprotein inhibitor IINon-inhibitor0.9148Renal organic cation transporterNon-inhibitor0.5832CYP450 2C9 substrateNon-substrate0.8603CYP450 2D6 substrateNon-substrate0.694CYP450 3A4 substrateNon-substrate0.7389CYP450 1A2 substrateInhibitor0.9606CYP450 2C9 inhibitorInhibitor0.7376CYP450 2D6 inhibitorNon-inhibitor0.5514CYP450 2C19 inhibitorInhibitor0.8681CYP450 3A4 inhibitorInhibitor0.5CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.8115Ames testAMES toxic0.5086CarcinogenicityNon-carcinogens0.5457BiodegradationNot ready biodegradable0.911Rat acute toxicity2.6796 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8497hERG inhibition (predictor II)Non-inhibitor0.5944  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. cAMP-dependent protein kinase catalytic subunit alphaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionUbiquitin protein ligase bindingSpecific FunctionPhosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which bin...Gene NamePRKACAUniprot IDP17612Uniprot NamecAMP-dependent protein kinase catalytic subunit alphaMolecular Weight40589.38 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details2. cAMP-dependent protein kinase inhibitor alphaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionProtein kinase a catalytic subunit bindingSpecific FunctionExtremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulato...Gene NamePKIAUniprot IDP61925Uniprot NamecAMP-dependent protein kinase inhibitor alphaMolecular Weight7988.435 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 